Ristova 500 mg Injection
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Ristova 500 mg Injection

Ristova 500 mg Injection

Ristova 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used for certain blood cancers and autoimmune conditions. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. Rituximab targets CD20-positive B cells and helps reduce abnormal B-cell activity.

BUY NOW

Category

Ristova 500 mg Injection is used in conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and certain blood-vessel disorders. Rituximab binds to the CD20 antigen on B cells and promotes their removal through immune-mediated mechanisms. The dose and infusion schedule are determined by the treating specialist according to the patient’s condition and treatment protocol. Medical supervision during administration is important because infusion-related reactions can occur.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Concentrate for Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 50 mL in 1 Vial
Manufacturer/Marketer Roche Products India Pvt Ltd

Product Also Known As

Ristova 500 mg Injection, Ristova 500 Injection, Ristova Rituximab Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL Infusion, Rituximab Monoclonal Antibody Injection